| Mainehealth Care At Home | |
| 15 Industrial Park Road, Saco, Maine 4072 | |
| (207) 284-4566 | |
| Name | Mainehealth Care At Home |
|---|---|
| Location | 15 Industrial Park Road, Saco, Maine |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 207000 |
| Ownership Type | Voluntary Non-profit - Other |
| Service Area Zip Codes | 3901, 3902, 3903, 3904, 3905, 3906, 3907, 3908, 3909, 3911, 4001, 4002, 4004, 4005, 4006, 4009, 4010, 4011, 4014, 4015, 4017, 4020, 4021, 4022, 4024, 4027, 4028, 4029, 4030, 4032, 4037, 4038, 4039, 4040, 4041, 4042, 4043, 4046, 4047, 4048, 4049, 4051, 4054, 4055, 4056, 4057, 4061, 4062, 4063, 4064, 4068, 4069, 4070, 4071, 4072, 4073, 4074, 4076, 4077, 4078, 4079, 4082, 4083, 4084, 4085, 4086, 4087, 4088, 4090, 4091, 4092, 4093, 4094, 4095, 4096, 4097, 4098, 4101, 4102, 4103, 4104, 4105, 4106, 4107, 4108, 4109, 4110, 4112, 4116, 4220, 4222, 4260, 4270, 4341, 4342, 4348, 4353, 4354, 4412, 4438, 4444, 4496, 4535, 4537, 4538, 4539, 4541, 4543, 4544, 4547, 4551, 4553, 4554, 4555, 4556, 4558, 4563, 4564, 4568, 4571, 4572, 4573, 4574, 4575, 4576, 4578, 4841, 4843, 4847, 4848, 4849, 4850, 4851, 4854, 4855, 4856, 4858, 4859, 4860, 4861, 4862, 4863, 4864, 4865, 4901, 4915, 4921, 4941, 4949, 4951, 4952, 4973, 4974, 4981, 4986, 4987, 4988 |
| NPI Number | 1275510844 |
| Organization Name | MAINEHEALTH CARE AT HOME |
| Address | 15 Industrial Park Rd, Saco, ME 04072 |
| Phone Number | 207-284-4566 |
News Archive
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it. The result is a boost in antitumor activity while minimizing side effects. The findings of this study have been published in the Journal of the American Chemical Society.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
The Perinatal Network of Monroe County and the Finger Lakes Health Systems Agency in New York state on Friday will unveil a series of 13 initiatives that aim to reduce racial health disparities, the Rochester Democrat and Chronicle reports.
A Newcastle University study involving thousands of families is helping prospective parents work out whether they are likely to have sons or daughters.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
› Verified 1 days ago
| NPI Number | 1376514224 |
| Organization Name | MAINEHEALTH CARE AT HOME |
| Doing Business As | KNO-WAL-LIN HOME CARE AND HOSPICE, INC. |
| Address | 815 Commercial St Unit 6, Rockport, ME 04856 |
| Phone Number | 207-284-4566 |
News Archive
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it. The result is a boost in antitumor activity while minimizing side effects. The findings of this study have been published in the Journal of the American Chemical Society.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
The Perinatal Network of Monroe County and the Finger Lakes Health Systems Agency in New York state on Friday will unveil a series of 13 initiatives that aim to reduce racial health disparities, the Rochester Democrat and Chronicle reports.
A Newcastle University study involving thousands of families is helping prospective parents work out whether they are likely to have sons or daughters.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
› Verified 1 days ago
| Quality Rating: |
News Archive
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it. The result is a boost in antitumor activity while minimizing side effects. The findings of this study have been published in the Journal of the American Chemical Society.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
The Perinatal Network of Monroe County and the Finger Lakes Health Systems Agency in New York state on Friday will unveil a series of 13 initiatives that aim to reduce racial health disparities, the Rochester Democrat and Chronicle reports.
A Newcastle University study involving thousands of families is helping prospective parents work out whether they are likely to have sons or daughters.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 86 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 98.6 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.7 | 99.6 |
| How often the home health team checked patients for depression | 99.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 77.6 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.7 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 93.2 | 96.4 |
News Archive
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it. The result is a boost in antitumor activity while minimizing side effects. The findings of this study have been published in the Journal of the American Chemical Society.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
The Perinatal Network of Monroe County and the Finger Lakes Health Systems Agency in New York state on Friday will unveil a series of 13 initiatives that aim to reduce racial health disparities, the Rochester Democrat and Chronicle reports.
A Newcastle University study involving thousands of families is helping prospective parents work out whether they are likely to have sons or daughters.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 72 | 79.6 |
| How often patients got better at getting in and out of bed | 79.2 | 81.1 |
| How often patients got better at bathing | 76.9 | 82.3 |
| How often patients’ breathing improved | 75.4 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 89.8 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 68.4 | 75 |
| How often home health patients had to be admitted to the hospital | 13.8 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 16.1 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 97 | 94 |
News Archive
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it. The result is a boost in antitumor activity while minimizing side effects. The findings of this study have been published in the Journal of the American Chemical Society.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
The Perinatal Network of Monroe County and the Finger Lakes Health Systems Agency in New York state on Friday will unveil a series of 13 initiatives that aim to reduce racial health disparities, the Rochester Democrat and Chronicle reports.
A Newcastle University study involving thousands of families is helping prospective parents work out whether they are likely to have sons or daughters.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
› Verified 1 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it. The result is a boost in antitumor activity while minimizing side effects. The findings of this study have been published in the Journal of the American Chemical Society.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
The Perinatal Network of Monroe County and the Finger Lakes Health Systems Agency in New York state on Friday will unveil a series of 13 initiatives that aim to reduce racial health disparities, the Rochester Democrat and Chronicle reports.
A Newcastle University study involving thousands of families is helping prospective parents work out whether they are likely to have sons or daughters.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
› Verified 1 days ago
The patient survey data of Mainehealth Care At Home is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 84 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 87 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 86 | 78 |
News Archive
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it. The result is a boost in antitumor activity while minimizing side effects. The findings of this study have been published in the Journal of the American Chemical Society.
The Affordable Care Act - Obamacare - has endured so many near-death experiences that digging into the details of still another effort to demolish it is admittedly not an inviting prospect. (My own reaction, I confess, to hearing some months back about the latest legal challenge - this one aimed at the supposed effect of a single word in the 900-page statute - was something along the lines of "wake me when it's over.") But stay with me, because this latest round, catapulted onto the Supreme Court's docket earlier this month by the same forces that brought us the failed Commerce Clause attack two years ago, opens a window on raw judicial politics so extreme that the saga so far would be funny if the potential consequences weren't so serious (Linda Greenhouse, 8/20).
The Perinatal Network of Monroe County and the Finger Lakes Health Systems Agency in New York state on Friday will unveil a series of 13 initiatives that aim to reduce racial health disparities, the Rochester Democrat and Chronicle reports.
A Newcastle University study involving thousands of families is helping prospective parents work out whether they are likely to have sons or daughters.
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
› Verified 1 days ago
Mainehealth Care At Home Location: 15 Industrial Park Road, Saco, Maine 4072 Ratings: Phone: (207) 284-4566 | |
Able Home Health Location: 209 Main Street, Suite 104, Saco, Maine 4072 Ratings: Phone: (207) 282-1699 |